Cargando…
Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor
melanoma differentiation associated gene-7 or Interleukin-24 (mda-7, IL-24) displays expansive anti-tumor activity without harming corresponding normal cells/tissues. This anticancer activity has been documented in vitro and in vivo in multiple preclinical animal models, as well as in patients with...
Autores principales: | Pradhan, Anjan K., Bhoopathi, Praveen, Maji, Santanu, Kumar, Amit, Guo, Chunqing, Mannangatti, Padmanabhan, Li, Jiong, Wang, Xiang-Yang, Sarkar, Devanand, Emdad, Luni, Das, Swadesh K., Fisher, Paul B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988683/ https://www.ncbi.nlm.nih.gov/pubmed/35402258 http://dx.doi.org/10.3389/fonc.2022.812560 |
Ejemplares similares
-
Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective Promoter
por: Bhoopathi, Praveen, et al.
Publicado: (2022) -
Theranostic Tripartite Cancer Terminator Virus for Cancer Therapy and Imaging
por: Bhoopathi, Praveen, et al.
Publicado: (2021) -
Regulation of neuroblastoma migration, invasion and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin
por: Bhoopathi, Praveen, et al.
Publicado: (2019) -
Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity
por: Bhoopathi, Praveen, et al.
Publicado: (2023) -
Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein
por: Modi, Jinkal, et al.
Publicado: (2021)